Navigation Links
Vital step in cellular migration described by UCSD medical researchers

A vital molecular step in cell migration, the movement of cells within the body during growth, tissue repair and the body's immune response to invading pathogens, has been demonstrated by researchers in the University of California, San Diego (UCSD) School of Medicine. Published in the March 27 online edition of Nature Cell Biology and the journal's upcoming April print edition, the study describes how a the interaction of alpha4 integrin adhesion receptor with a protein called paxillin creates directional movement of a cell by inhibiting a protein called Rac.

"Understanding how this protein contributes to directional movement of a cell provides a new insight into cell migration and ultimately could lead to therapeutic interventions in autoimmune diseases such as multiple sclerosis and Crohn's disease," said the paper's first author Naoyuki Nishiya, Ph.D., a postgraduate researcher in the lab of senior author Mark Ginsberg, M.D., UCSD professor of medicine. "Since cell migration plays an important role in the immune response, as leukocytes move toward targets, a therapy that stops that movement could potentially help in autoimmune disorders where the body's immune system incorrectly attacks the body's own tissue."

From the genesis of human life to birth and beyond, cell migration is a complex, extremely important process that is not completely understood by researchers. In order to move, a cell must be polarized so that the molecular processes at the front end and back end are different, leading only to forward movement. One of the first steps in cell migration is the initiation of activity by Rac that extends protrusions out of the cell. These protrusions serve as tractor sites for migration as the cell moves toward its intended target. If Rac were active throughout the cell, it would extend protrusions in all directions, in essence keeping the cell in one place.

Until now, researchers have had limited understanding of the molecular mechanism that inhibits Rac activity in the back of the cell, to maintain directional movement. In laboratory experiments with human and animal cells, the UCSD team discovered that the alpha4 integrin recruits enzymes that block Rac activity only at the rear of a crawling cell.

The scientists noted that alpha4 integrins are widely expressed in neural crest cells, immune system leukocytes (such as T cells), striated and smooth muscle, and neurons. For this reason, they believe the mechanism used by alpha4 integrins to localize Rac activity may participate in a wide variety of cell migratory and pathfinding events.

In addition to Nishiya and Ginsberg, additional authors were William B. Kiosses, Ph.D., The Scripps Research Institute, La Jolla, California; and Jaewon Han, Ph.D., UCSD Department of Medicine. The study was funded by the National Institutes of Health.


'"/>

Source:University of California - San Diego


Related biology news :

1. Vital ocean prey play active role in environment
2. Scientists discover the cellular roots of graying hair
3. MSI releases moleculizer - a new approach to simulation of intracellular biochemical networks
4. New study to explore cellular circuitry
5. Study provides insight into cellular defenses against genetic mutation
6. Carnegie Mellon develops non-invasive technique to detect transplant rejection at cellular level
7. Liver cancer linked to cellular repair pathway
8. New cellular flaw found in some virulent breast cancers
9. Insects that produce males from unfertilized eggs reveal a surprising cellular feat
10. University of Minnesota researchers take new look at cellular suicide
11. RNA found in the cellular centrosome of surf clams
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/7/2018)... ... 06, 2018 , ... BioMedGPS announces the launch of SmartTRAK ... its medical device customers, BioMedGPS teamed up with a usability expert to help ... 3.0 touts a cleaner look, easier navigation and improved functionality. , SmartTRAK ...
(Date:8/2/2018)... ... August 02, 2018 , ... RxS LLC (“RxS”), ... companies, today announced that Mark Jara, principal of the organization, has been named ... sciences industry. Individuals named to PharmaVOICE 100 are leaders who drive the industry ...
(Date:8/1/2018)... , ... August 01, 2018 , ... Visikol CEO Dr. ... services and strong pharmaceutical company partnerships that Visikol will far exceed its original 2018 ... developing its suite of digital pathology tools, whole mount imaging ...
Breaking Biology News(10 mins):
(Date:7/25/2018)... ... July 25, 2018 , ... Dimitrius ... proprietary nutraceutical to combat inflammation and autoimmune disorders. , The preclinical research ... The following data was reported:, Over 70% decrease ...
(Date:7/25/2018)... MELBOURNE, Fla. (PRWEB) , ... July 25, 2018 ... ... of Podiatric Medicine (NYCPM) & Foot Center of New York’s (FCNY) acquisition of ... NYCPM provides unrivaled excellence in podiatric medical education and clinical experience. Their ...
(Date:7/25/2018)... Ind. (PRWEB) , ... July 25, 2018 , ... ... of Things (IoT) Systems Innovator, joined the board of the Indiana India Business ... Nominated and unanimously elected today by the current board of directors, McDonald joins ...
(Date:7/24/2018)... (PRWEB) , ... July 24, 2018 , ... R3 Stem ... in Las Vegas. The treatments are offered by Double Board Certified providers, with outcomes ... mostly okay with suppressing symptoms, but have done nothing to help repair and regenerate ...
Breaking Biology Technology: